Results 81 to 90 of about 1,654 (168)

Replication of blood DNA methylomic signatures associated with cerebrospinal fluid levels of YKL‐40 and NfL biomarkers

open access: yes
Alzheimer's &Dementia, Volume 21, Issue 9, September 2025.
Timo Kaleck   +34 more
wiley   +1 more source

Understanding Buerger's Disease: Symptoms, Diagnosis and Management Strategies

open access: yesQuality in Sport
Buerger's disease, also known as thromboangiitis obliterans (TAO), is a rare but serious condition that primarily affects the blood vessels in the limbs.
Adrianna Muciek   +7 more
doaj   +1 more source

Immunological Changes Related to Smoking in Buerger’s Disease (Thromboangiitis Obliterans): A Systematic Review [PDF]

open access: yesDisease and Diagnosis
Thromboangiitis obliterans (TAO), or Buerger’s disease (BD), is a progressive inflammatory condition that affects small and medium arteries, primarily in the limbs, and is strongly associated with tobacco use.
Narges Khaghanzadeh   +3 more
doaj   +1 more source

Advancements in mesenchymal stem cell treatment for Buerger's disease [PDF]

open access: yes, 2017
Birgerova bolest (thromboangiitis obliterans) je neaterosklerotski inflamatorni proces koji uglavnom zahvata male i srednje arterije i vene u donjim i gornjim udovima. Okarakterisan je kao vrsta vaskulitisa.
Fazlagić, Amira   +6 more
core   +1 more source

Investing in America's Health 2012: A State-By-State Look at Public Health Funding and Key Health Facts [PDF]

open access: yes, 2012
Examines federal and state public health funding for preventive care and state variations in disease rates, healthcare access, and other data.

core  

The Incidence and Prevalence of Thromboangiitis Obliterans in Taiwan: A Nationwide, Population-based Analysis of Data Collected from 2002 to 2011 [PDF]

open access: yes, 2016
OBJECTIVE: To estimate the incidence and prevalence of thromboangiitis obliterans in Taiwan in the period spanning from 2002 to 2011. METHODS: We identified all incident and prevalent cases with a diagnosis of thromboangiitis obliterans (International ...
Chen, Der-Yuan   +4 more
core   +3 more sources

Angiogenesis induction in Buerger's disease: a disease management double-edged sword?

open access: yesOrphanet Journal of Rare Diseases, 2019
Due to unknown aetiology of Thromboangiitis obliterans (TAO), its effectively treating is challenging. However, angiogenesis induction is one of the acceptable treatments for TAO patients.
Bahare Fazeli   +3 more
doaj   +1 more source

Management of Buerger's disease during pregnancy. [PDF]

open access: yesBMJ Case Rep, 2023
Sousa Silva ÂE   +3 more
europepmc   +1 more source

Smoking characteristics and cessation in patients with thromboangiitis obliterans

open access: yesMonaldi Archives for Chest Disease, 2016
Aim. Describe the smoking characteristics and the results of a smoking intervention programme involving 27 cigarette smokers with Thromboangiitis Obliterans (TAO). Methods.
C.A. Jiménez-Ruiz   +5 more
doaj   +1 more source

Physical Activity and Other Strategies in Treatment of Buerger’s Disease - a Systematic Review

open access: yesQuality in Sport
Buerger's disease, also known as Thromboangitis obliterans (TAO), is a nonatherosclerotic vascular disorder of unknown etiology, causing distal arterial occlusions. Implication of changes in the vessels is decreased blood flow and ischemia as the result.
Julia Kaczmarek   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy